2025 Annual Meeting | C147 - Diagnosis and Treatment of Multiple Sclerosis in Diverse Populations

Date Tuesday 04/08/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 6A

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jaime Imitola, MD, FAAN

Topic(s) Health Care Disparities, Multiple Sclerosis

Learning Objectives Participants should gain an understanding of the current data on the incidence and prevalence of MS in diverse populations and unique geographic distributions; the biological principles that underlie the emergent views of pathology and progression of multiple sclerosis among African American, Asian, Hispanic populations, which are the faster-growing demographics in the US; current challenges of health care disparities affecting diverse populations; emerging data of MS throughout the lifespan affecting minorities, i.e., pediatric-onset MS, aging in MS; mimickers, typical and atypical clinical presentations of MS in diverse populations; emerging clinical trial data for RCTs in diverse populations; how MS affects various communities differently and how its diagnosis and treatment present challenges specific to population groups; data from the patient experience and registries; considerations to practicing neurologists of strategies to overcome cultural factors and perceptions from patients and families about MS care to avoid delayed diagnosis or inadequate treatment; and practical strategies to foster patient-centered care in diverse populations, building trust, patient education, self-agency, with opportunities and resources from the AAN to improve care in these populations.

This program is supported in part by educational grants from Novartis and Sanofi

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Diversity, Equity, and Inclusion

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	What Diverse Populations with MS Can Teach Us About Prodrome, Prevention, Progression, and Delivery of Care? Jaime Imitola, MD, FAAN
01:05 PM - 01:40 PM PDT	Speaker	The Relationship Between Social Determinants and Multiple Sclerosis across Risk, Prodrome, and Outcomes in the United Kingdom Ruth Dobson
01:40 PM - 02:15 PM PDT	Speaker	Diagnosing Multiple Sclerosis in Diverse Populations and Geographies Lilyana M. Amezcua, MD, FAAN
02:15 PM - 02:50 PM PDT	Speaker	Disease-modifying Therapies and Real-world Strategies to improve Care Throughout the Lifespan in Diverse Populations with MS Jaime Imitola, MD, FAAN
02:50 PM - 03:00 PM PDT	Q&A	Questions and Answers Jaime Imitola, MD, FAAN, Lilyana M. Amezcua, MD, FAAN, Ruth Dobson

Faculty Disclosures
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Lilyana M. Amezcua, MD, FAAN	Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Medday. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS.
Ruth Dobson	The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . The institution of Ruth Dobson has received research support from NMSS. The institution of Ruth Dobson has received research support from MS Society UK . The institution of Ruth Dobson has received research support from BMA Foundation . The institution of Ruth Dobson has received research support from Biogen . The institution of Ruth Dobson has received research support from Merck . The institution of Ruth Dobson has received research support from Horne Family Charitable Trust . The institution of Ruth Dobson has received research support from MRC.

��ɫ��

��ɫ��